TY - JOUR
T1 - Dynactin is involved in Lewy body pathology
AU - Shen, Chang
AU - Honda, Hiroyuki
AU - Suzuki, Satoshi
AU - Maeda, Norihisa
AU - Shijo, Masahiro
AU - Hamasaki, Hideomi
AU - Sasagasako, Naokazu
AU - Fujii, Naoki
AU - Iwaki, Toru
N1 - Funding Information:
Funding for this study was provided by a Grant-in-Aid for Scientific Research (17 K07097 and 26290017) from the Japan Society for the Promotion of Science (JSPS). The authors have no conflicts of interest to declare.
Funding Information:
The authors thank Ms. Sachiko Koyama and Mr. Tsuyoshi Negi for their technical assistance (Department of Neuropathology, Kyushu University), and Ms. Shigemi Takami (The Research Support Center, Research Center for Human Disease Modeling Kyusyu University). We thank Ann Turnley, PhD, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.
Publisher Copyright:
© 2018 Japanese Society of Neuropathology
PY - 2018/12
Y1 - 2018/12
N2 - Dynactin forms a protein complex with dynein that retrogradely transports cargo along microtubules. Dysfunction of this dynein-dynactin complex causes several neurodegenerative diseases such as Perry syndrome, motor neuron diseases and progressive supranuclear palsy. Recently, we reported colocalization of phosphorylated α-synuclein (p-SNCA) and the largest subunit of dynactin (DCTN1) in Lewy body (LB)-like structures in Perry syndrome. Previous reports have not focused on the relationship between dynactin and synucleinopathies. Thus, we examined autopsied human brains from patients with Parkinson's disease, dementia with LBs, and multiple system atrophy using immunohistochemistry for p-SNCA, DCTN1, dynactin 2 (DCTN2, dynamitin) and dynein cytoplasmic 1 intermediate chain 1 (DYNC1I1). We also examined microtubule affinity-regulating kinases (MARKs), which phosphorylate microtubule-associated proteins and trigger microtubule disruption. Both brainstem-type and cortical LBs were immunopositive for DCTN1, DCTN2, DYNC1I1 and p-MARK and their staining often overlapped with p-SNCA. Lewy neurites were also immunopositive for DCTN1, DCTN2 and DYNC1I1. However, p-SNCA-positive inclusions of multiple system atrophy, which included both glial and neuronal cytoplasmic inclusions, were immunonegative for DCTN1, DCTN2, DYNC1I1 and p-MARK. Thus, immunohistochemistry for dynein-dynactin complex molecules, especially DCTN1, can clearly distinguish LBs from neuronal cytoplasmic inclusions. Our results suggest that dynactin is closely associated with LB pathology.
AB - Dynactin forms a protein complex with dynein that retrogradely transports cargo along microtubules. Dysfunction of this dynein-dynactin complex causes several neurodegenerative diseases such as Perry syndrome, motor neuron diseases and progressive supranuclear palsy. Recently, we reported colocalization of phosphorylated α-synuclein (p-SNCA) and the largest subunit of dynactin (DCTN1) in Lewy body (LB)-like structures in Perry syndrome. Previous reports have not focused on the relationship between dynactin and synucleinopathies. Thus, we examined autopsied human brains from patients with Parkinson's disease, dementia with LBs, and multiple system atrophy using immunohistochemistry for p-SNCA, DCTN1, dynactin 2 (DCTN2, dynamitin) and dynein cytoplasmic 1 intermediate chain 1 (DYNC1I1). We also examined microtubule affinity-regulating kinases (MARKs), which phosphorylate microtubule-associated proteins and trigger microtubule disruption. Both brainstem-type and cortical LBs were immunopositive for DCTN1, DCTN2, DYNC1I1 and p-MARK and their staining often overlapped with p-SNCA. Lewy neurites were also immunopositive for DCTN1, DCTN2 and DYNC1I1. However, p-SNCA-positive inclusions of multiple system atrophy, which included both glial and neuronal cytoplasmic inclusions, were immunonegative for DCTN1, DCTN2, DYNC1I1 and p-MARK. Thus, immunohistochemistry for dynein-dynactin complex molecules, especially DCTN1, can clearly distinguish LBs from neuronal cytoplasmic inclusions. Our results suggest that dynactin is closely associated with LB pathology.
UR - http://www.scopus.com/inward/record.url?scp=85053446535&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053446535&partnerID=8YFLogxK
U2 - 10.1111/neup.12512
DO - 10.1111/neup.12512
M3 - Article
C2 - 30215870
AN - SCOPUS:85053446535
VL - 38
SP - 583
EP - 590
JO - Neuropathology
JF - Neuropathology
SN - 0919-6544
IS - 6
ER -